Cancer Drug's Real-World side effects under watch in south korea
NCT ID NCT07035886
Summary
This study is monitoring the safety and effectiveness of Fruzaqla (fruquintinib) in real-world colorectal cancer patients in South Korea. Researchers will track side effects and survival outcomes in 600 adults taking this already-approved medication. The goal is to better understand how the drug performs outside of controlled clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yonsei University Hospital
RECRUITINGSeoul, 03722, South Korea
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.